Skip to main navigation
  • IR Home
  • News
  • Events & Presentations
  • Governance
    • Our Team
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financials
    • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

Apr 10, 2024
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Apr 01, 2024
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
Mar 12, 2024
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 26, 2024
Rallybio to Present at the TD Cowen 44th Annual Health Care Conference
Feb 06, 2024
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
Jan 04, 2024
Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Displaying 21 - 26 of 26

Investor Tools

Unimagined therapies. Undreamed outcomes.

Rallybio Newsroom
Linkedin Twitter

info@rallybio.com

234 Church Street
Suite 1020
New Haven, CT 06510

+1 203-859-3820
+1 475-47-RALLY (72559)

© 2024 Rallybio | Terms of Use | Privacy Policy | Community Guidelines